echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Feed Industry News > The first domestic human avian influenza insurance came out in Chengdu

    The first domestic human avian influenza insurance came out in Chengdu

    • Last Update: 2008-11-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Introduction: the first domestic personal insurance product specifically for human avian influenza has been reported and approved by CIRC Relevant people from Chengdu Branch of Minsheng life insurance said the insurance would be sold in Chengdu in the near future It is reported that two life insurance products of human avian influenza are named "special disease term life insurance" and "group special disease term life insurance", with an insurance period of one year There are two kinds of insurance amount: 100000 yuan or 50000 yuan depending on the specific situation of each policyholder.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.